Icotinib for Completed Resected IB NSCLC With EGFR Mutation

Clinical trial NCT02264210 · COMPLETED

Trial details

NCT number: NCT02264210
Sponsor: Sun Yat-sen University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Neoplasms Squamous Cell Lung Cancer Adenocarcinoma of the Lung Adenosquamous Cell Lung Cancer Large Cell Lung Cancer Bronchial Neoplasms Stage IB Non-small Cell Lung Cancer

Start date: 2015-01-01
Primary completion: 2020-12-01
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.